Co-Expression of Recombinant Human CYP2C9 with Human Cytochrome P450 Reductase in Protease Deficient S. cerevisiae Strain at a Higher Scale Yields an Enzyme of Higher Specific Activity

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|4|4|246-253

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.4, Iss.4, 2010-12, pp. : 246-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macaque CYP2C76 Encodes Cytochrome P450 Enzyme Not Orthologous to Any Human Isozymes

By  

Current Drug Metabolism, Vol. 11, Iss. 2, 2010-02 ,pp. : 142-152

Bentham Science Publishers

Access to resources Recommend Favorite

A Review on the Expression and Metabolic Features of Orphan Human Cytochrome P450 2S1 (CYP2S1)

By  

Current Drug Metabolism, Vol. 19, Iss. 11, 2018-09 ,pp. : 917-929

Bentham Science Publishers

Access to resources Recommend Favorite

Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development

By  

Current Medicinal Chemistry, Vol. 16, Iss. 27, 2009-09 ,pp. : 3480-3675

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Enzyme Sources on Midazolam 1-Hydroxylation Activity Catalyzed by Recombinant Cytochrome P450 3A4 in Combination with NADPH-Cytochrome P450 Reductase

By  

Drug Metabolism Letters, Vol. 2, Iss. 3, 2008-08 ,pp. : 190-192

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Recombinant Human Thymosin-1, an Immuno-Modulating Peptide with 28 Amino Acids, on the Activity of Cytochrome P450s

By  

Drug Metabolism Letters, Vol. 1, Iss. 3, 2007-08 ,pp. : 199-204

Bentham Science Publishers

Access to resources Recommend Favorite